Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.75p
   
  • Change Today:
      0.40p
  • 52 Week High: 12.50
  • 52 Week Low: 1.23
  • Currency: UK Pounds
  • Shares Issued: 782.06m
  • Volume: 19,413,982
  • Market Cap: £13.69m

Latest ShareCast News

Shield Therapeutics reports strong US progress

By Josh White

Date: Thursday 07 Dec 2023

(Sharecast News) - Iron deficiency-focussed pharmaceuticals company Shield Therapeutics announced significant achievements in the US commercialisation of Accrufer on Thursday.

Shield's Canadian partner files new drug submission for Accrufer

By Josh White

Date: Monday 21 Mar 2022

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory review and approval of the iron therapy 'Accrufer'.

Shield Therapeutics revenue falls in line with expectations

By Josh White

Date: Thursday 17 Feb 2022

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 1.75p
Change Today 0.40p
% Change 29.63 %
52 Week High 12.50
52 Week Low 1.23
Volume 19,413,982
Shares Issued 782.06m
Market Cap £13.69m

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
39.26% below the market average39.26% below the market average39.26% below the market average39.26% below the market average39.26% below the market average
60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average60.78% above the sector average
Price Trend
97.35% below the market average97.35% below the market average97.35% below the market average97.35% below the market average97.35% below the market average
96.43% below the sector average96.43% below the sector average96.43% below the sector average96.43% below the sector average96.43% below the sector average
Income Not Available
Growth
59.01% above the market average59.01% above the market average59.01% above the market average59.01% above the market average59.01% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 1
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 01-May-2024

Time Volume / Share Price
16:29 78,690 @ 1.74p
16:22 1,500,000 @ 1.70p
16:21 75,000 @ 1.79p
16:21 100,000 @ 1.78p
16:20 150,000 @ 1.79p

Top of Page